Olympus Scope Infection Lawsuit: Superbug & Sepsis Claims (2026)
Medical procedures like colonoscopies, endoscopies, and ERCPs are supposed to detect and treat illnesses, not introduce deadly new ones. Yet, thousands of patients across the United States have contracted severe, antibiotic-resistant infections after undergoing routine procedures involving reusable Olympus scopes.
At TheLawFirm.com, our attorneys provide critical updates on the expanding scope of this litigation, recent regulatory actions, and the legal rights of patients who have suffered life-threatening complications.
The Core Issue: A Design Inherently Deficient in Sterilization
The litigation against Olympus Medical Systems centers on a profound product liability claim: the physical design of their reusable gastrointestinal devices—including the TJF-Q180V, TJF-Q190V, and TJF-Q290V duodenoscopes—makes them nearly impossible to completely disinfect.
Even when hospital staff meticulously follow the manufacturer’s written sanitization protocols, microscopic crevices near the tip of the device can trap biomaterial and fluids from previous patients.
The Elevator Mechanism
Specialized scopes utilize a tiny, moveable “elevator” mechanism to guide surgical tools. This micro-component creates a breeding ground for bacteria that resists standard chemical washing.
Cross-Contamination
When the contaminated scope is used on a subsequent patient, trapped, drug-resistant bacteria can be introduced directly into internal organs and the bloodstream.
Serious Infections Tied to Olympus Scopes
Because the bacteria left behind are often “superbugs,” standard frontline antibiotics are frequently ineffective. Lawsuits are actively being reviewed for individuals diagnosed with:
CRE (Carbapenem-resistant Enterobacteriaceae)
An aggressive, drug-resistant bacterial infection carrying mortality rates reaching up to 50% if it enters the bloodstream.
Sepsis & Bacteremia
Systemic bloodstream infections that cause the immune system to attack organs, rapidly progressing to septic shock or multi-organ failure.
2026 Litigation Status: An Expanding Regulatory Crackdown
While initial waves of litigation targeted older duodenoscope models, current claims cover a wider variety of medical devices subject to ongoing federal scrutiny.
- FDA Regulatory & Import Actions: Federal advisories have placed dozens of Olympus scope models and automated endoscope reprocessors under increased import restrictions and Class II recalls due to infection risks.
- Ongoing Safety Alerts: Olympus has issued field safety notices advising facilities to inspect scope tips under 10X magnification for trapped debris—a requirement critics argue confirms the original design was fundamentally flawed.
- No MDL Consolidation (Yet): Lawsuits currently proceed as individual product liability actions, allowing for personalized strategy and direct settlement tracks.
Do You Qualify to File a Claim?
If you or a family member suffered a severe medical crisis following an endoscopic procedure, you may be entitled to financial compensation for medical bills, lost wages, and pain and suffering.
- A Coinciding Procedure: You underwent a colonoscopy, endoscopy, bronchoscopy, or ERCP procedure utilizing an Olympus device.
- Rapid Onset Infection: You were diagnosed with a superbug (like CRE), sepsis, tuberculosis, or another severe infection requiring hospitalization within 30 to 90 days of the procedure.
- Wrongful Death: Families may file survival or wrongful death claims if a loved one passed away from systemic shock or organ failure linked to a post-procedure infection.
Important Legal Context: Medical device companies frequently attempt to shift responsibility to hospital technicians for “improper cleaning”. However, public records confirm that Olympus previously failed to report known adverse infection events to federal regulators while continuing to sell contaminated scopes.
Strict Filing Deadlines Apply (Statute of Limitations)
State laws strictly limit the time frame to file a defective medical device lawsuit. Delaying action after an infection diagnosis may permanently bar your right to financial recovery.
Get a Free, Confidential Case Evaluation
If you or a loved one contracted a superbug infection or sepsis following a scope procedure, contact TheLawFirm.com today to review your eligibility.
- Centers for Disease Control and Prevention (CDC). Carbapenem-resistant Enterobacteriaceae (CRE) Guidance & Control.
- U.S. Food and Drug Administration (FDA). Safety Communication: Infections Associated with Reprocessed Reusable Duodenoscopes.
- U.S. Department of Justice (DOJ). (10 December 2018). Olympus Medical Systems Corp. and Former Senior Executive Plead Guilty to Distributing Misbranded Foreign-Manufactured Medical Devices.
- American Society for Gastrointestinal Endoscopy (ASGE). Guideline for Reprocessing Reusable Endoscopic Accessories and Infection Control.